Our Solutions

Patient Experience Lab

Bring patients into the room. Leave with something you can actually ship.

Book a Consultation

patient experts

in the active network

disease areas

with patient-expert coverage

Patient Experience Labs

delivered for pharma, medtech & patient orgs

What ships

You leave with something you can deploy

Patient-facing

A deployable brochure

Clinical content rewritten into language and decisions patients can act on.

Service design

A service blueprint

The patient journey mapped end-to-end, with the touchpoints that move adoption.

Go-to-market

An implementation plan

A market-by-market rollout, grounded in real patient and health-system context.

How a Patient Experience Lab differs

	Conventional research (focus group, advisory board)	Patient Experience Lab
Patient role	Participants — answer questions	Co-designers — shape brief, sessions, output
Input	Opinion extracted from a session	Brief co-built before the work starts
Output	Slide deck of findings	Deployable artefact (brochure, blueprint, plan)
Time to use	Findings need translation to action	Ships ready to deploy in your market
Multi-market readiness	Validated in one market, extrapolated to others	Built with multi-country patient experts from day one

How a Lab works

From brief to shipped artefact

Scope

Frame the question and the output.

Assemble

Patient experts + a merakoi team.

Co-create

Mixed sessions, iterating live.

Ship

A usable artefact, ready to deploy.

The mix, sequenced to fit — tap to explore:

Async touchpoints

Patients contribute in their own time — short reflections, diaries, and reactions between live sessions.

Individual

One-to-one depth where the question is sensitive or the lived experience is highly personal.

Group

Patient experts build on each other, surfacing the patterns a single voice would miss.

Co-design workshops

Patients and your team work the artefact together, iterating toward something deployable.

Case Study · Diagnostics & heart failure

Global diagnostics company, heart failure detection in type 2 diabetes

A multi-country Lab co-designed how high-risk type 2 diabetes patients are encouraged to test for heart failure — and how their results are explained back to them.

Two deployable outputs

Patient diagnostic brochure — translates clinical results into language and decisions patients can act on.
Multi-country implementation plan — culture- and health-system-specific recommendations for each market.

The result: a single-market clinical asset became a deployable, patient-facing program.

See related case studies →

Chelsea, patient expert and lead co-designer living with pulmonary arterial hypertension

In the patient's words

“It is so meaningful for patients to have a voice in creating solutions.”

Chelsea

Patient expert & lead co-designer

Built with patients,
not about them.

Shaped by the people who use it — so it actually gets adopted.

Frequently asked questions

Isn't this just an expensive focus group?

Focus groups and advisory boards extract opinion: patients answer your questions and you leave with findings to interpret. The Patient Experience Lab co-designs the deliverable itself. Patients shape the brief, the sessions, and the output, and you leave with a usable artefact rather than a slide deck.

What is a Patient Experience Lab?

A working partnership between patient experts and a multi-disciplinary merakoi team. We co-design the brief, run a combination of asynchronous touchpoints, individual and group sessions, and co-design workshops, then ship a deployable artefact you can use in your market.

What kind of output does a Patient Experience Lab produce?

Concrete, deployable artefacts: a patient-facing brochure, a service blueprint, a content plan, an implementation guide. The output is decided up-front and built collaboratively, so it ships ready to use rather than waiting for translation.

Who is the Patient Experience Lab for?

Pharma and medtech teams use Labs for product programs, patient materials, and service design. Payer and HTA teams use them for engagement and access work. The methodology adapts to the question; the structure stays the same.

How long does a Patient Experience Lab take?

Typically 8 to 12 weeks from scoping to deployable artefact. Faster Labs (4 to 6 weeks) are possible when the brief is tight and the patient cohort is already accessible through our network.

What is the Patient Safety Experience Lab (PSEL)?

A specialised Patient Experience Lab focused on safety, benefit-risk, and pharmacovigilance work. Same co-design methodology, applied to the questions where regulatory and risk-management teams need patient-experience grounding.

Can a Lab run alongside other research?

Yes — Labs slot in around other research streams. They sit after early-stage discovery (where focus groups or surveys still fit), and before or instead of a traditional service-design engagement. When a project already has a quant base or a service-design partner, the Lab focuses where co-design with patients changes the answer — the deliverable shape, the language, the adoption logic — rather than re-running upstream discovery.

Book a Consultation to talk to us about your Lab.

A short call to shape the output, the cadence, and the patient experts who'd join.

Book a Consultation

Patient Experience Lab (PEL)

Patient-Led Market Research

Patient Testing Panels

Patient Expert Connect (PEC)

Patient-Led Market Research

Patient Experience Panels

Patient Experience Lab